A detailed history of Vanguard Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Vanguard Group Inc holds 73,773,467 shares of LLY stock, worth $55.6 Billion. This represents 1.2% of its overall portfolio holdings.

Number of Shares
73,773,467
Previous 73,859,008 0.12%
Holding current value
$55.6 Billion
Previous $66.9 Billion 2.26%
% of portfolio
1.2%
Previous 1.31%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $66 Million - $82.1 Million
-85,541 Reduced 0.12%
73,773,467 $65.4 Billion
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $808 Million - $1.01 Billion
1,113,997 Added 1.53%
73,859,008 $66.9 Billion
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $671 Million - $898 Million
1,133,810 Added 1.58%
72,745,011 $56.6 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $544 Million - $641 Million
1,035,599 Added 1.47%
71,611,201 $41.7 Billion
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $287 Million - $395 Million
659,838 Added 0.94%
70,575,602 $37.9 Billion
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $28.6 Million - $38.3 Million
-81,618 Reduced 0.12%
69,915,764 $32.8 Billion
Q1 2023

Jul 14, 2023

BUY
$310.63 - $364.82 $2.86 Million - $3.36 Million
9,199 Added 0.01%
69,997,382 $24 Billion
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $1.07 Billion - $1.26 Billion
-3,441,680 Reduced 4.69%
69,988,183 $24 Billion
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $271 Million - $315 Million
841,546 Added 1.16%
73,429,863 $26.9 Billion
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $296 Million - $337 Million
996,990 Added 1.39%
72,588,317 $23.5 Billion
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $309 Million - $363 Million
1,110,149 Added 1.58%
71,591,327 $23.2 Billion
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $286 Million - $356 Million
1,219,424 Added 1.76%
70,481,178 $20.2 Billion
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $49.2 Million - $61 Million
218,594 Added 0.32%
69,261,754 $19.1 Billion
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $16.3 Million - $20.1 Million
73,612 Added 0.11%
69,043,160 $16 Billion
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $12.5 Billion - $16.1 Billion
68,969,548 New
68,969,548 $15.8 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.